Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 557

Similar articles for PubMed (Select 6143767)

1.

A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.

Mamelak M, Csima A, Price V.

J Clin Pharmacol. 1984 Feb-Mar;24(2-3):65-75.

PMID:
6143767
2.

Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).

Saletu B, Anderer P, Brandstätter N, Frey R, Grünberger J, Klösch G, Mandl M, Wetter T, Zeitlhofer J.

Neuropsychobiology. 1994;29(2):69-90.

PMID:
8170529
3.

Sleep laboratory study of lormetazepam in older insomniacs.

Vogel GW.

Psychopharmacology Suppl. 1984;1:69-78.

PMID:
6147842
4.

Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.

Kales A, Bixler EO, Vela-Bueno A, Soldatos CR, Niklaus DE, Manfredi RL.

Clin Pharmacol Ther. 1986 Oct;40(4):378-86.

PMID:
3530586
6.

Quazepam: hypnotic efficacy and side effects.

Kales A.

Pharmacotherapy. 1990;10(1):1-10; discussion 10-2. Review.

PMID:
1969151
7.

Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.

Kales A, Kales JD.

J Clin Psychopharmacol. 1983 Apr;3(2):140-50. Review.

PMID:
6132933
8.

Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.

Mamelak M, Csima A, Price V.

Clin Neuropharmacol. 1985;8 Suppl 1:S63-73. No abstract available.

PMID:
3837688
9.
10.

Quazepam and flurazepam: long-term use and extended withdrawal.

Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, Kales JD.

Clin Pharmacol Ther. 1982 Dec;32(6):781-8.

PMID:
7140142
11.

Rebound insomnia: a critical review.

Gillin JC, Spinweber CL, Johnson LC.

J Clin Psychopharmacol. 1989 Jun;9(3):161-72. Review.

PMID:
2567741
12.

[Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs].

Stepanski E, Zorick F, Kaffeman M, Sicklesteel J, Roth T.

Nouv Presse Med. 1982 Oct 14;11(40):2987-90. French.

PMID:
6128721
13.

Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.

Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby JA, Kales JD.

Clin Pharmacol Ther. 1986 Mar;39(3):345-52.

PMID:
2868823
14.

Hypnotic effects of low doses of quazepam in older insomniacs.

Roth TG, Roehrs TA, Koshorek GL, Greenblatt DJ, Rosenthal LD.

J Clin Psychopharmacol. 1997 Oct;17(5):401-6.

PMID:
9315991
15.

Quazepam versus triazolam in patients with sleep disorders: a double-blind study.

Mauri MC, Gianetti S, Pugnetti L, Altamura AC.

Int J Clin Pharmacol Res. 1993;13(3):173-7.

PMID:
7901174
16.

The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.

Tietz EI, Roth T, Zorick FJ, Piccione P, Kramer M.

Arzneimittelforschung. 1981;31(11):1963-6.

PMID:
6119098
17.

[Controlled clinical study on the effect of quazepam versus triazolam in patients with sleep disorders].

Altamura AC, Colacurcio F, Mauri MC, De Vanna M, Rigamonti R, Maj M, Veltro F, Pancheri P, Delle Chiaie R, Porta M, et al.

Minerva Psichiatr. 1989 Jul-Sep;30(3):159-64. Italian.

PMID:
2691808
18.

Nighttime versus daytime hypnotic self-administration.

Roehrs T, Bonahoom A, Pedrosi B, Zorick F, Roth T.

Psychopharmacology (Berl). 2002 May;161(2):137-42. Epub 2002 Mar 14.

PMID:
11981593
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk